Identification of miR-101-3p targets and functional features based on bioinformatics, meta-analysis and experimental verification in hepatocellular carcinoma.

Chunyao Li, Yu‐Yan Pang, Hong Yang, Jia Li, Haixia Lu, Hanlin Wang, Wei‐Jia Mo, Lanshan Huang, Zhen‐Bo Feng, Gang Chen

PubMed · 2017 · 25 citations · 34 references

Concepts

Abstract

BACKGROUND: MiR-101-3p has been reported to suppress invasion and metastasis in hepatocellular carcinoma (HCC) cells. However, the relevant mechanisms are still unclear. The research seeks to determine systematic value of miR-101-3p in HCC, and comprehensively summarize the predicted target genes as well as their potential function, pathways and networks in HCC. METHODS: experiments in HCC cells. RESULTS: experiments demonstrated that miR-101-3p inhibited proliferation and promoted apoptosis in HCC cells. CONCLUSIONS: MiR-101-1 may be a prospective biomarker for diagnosis and prognosis of HCC. Potential targets of miR-101-3p could regulate genesis and development of HCC. The data offers insights into biological significances and promising targets of miR-101-3p for further investigation and potential therapies in HCC.

References

34